Niaid Trial Of Remdesivir Met Its 'Primary Goal': Gilead

NIAID trial of remdesivir met its 'primary goal': Gilead

CNBC Television

Breaking the Blind | NIH/NIAID COVID Remdesivir Preliminary Clinical Trial Results | Explained

Albert Einstein College of Medicine

Fauci: Gilead's Remdesivir Drug Trials Show ‘Good News' Against Covid-19 Fight

Bloomberg Quicktake

All you need to know about Gilead's Remdesivir

Dr. Anthony Fauci's positive comments on using Gilead's Remdesivir to treat coronavirus

CNBC Television

Remdesivir is part of a coronavirus treatment 'toolbox,' not a cure: Dr. Scott Gottlieb

CNBC Television

Gilead’s Remdesivir May Be A Potential Treatment Of COVID-19

CRUX

Data from remdesivir coronavirus drug trial shows 'quite good news': Dr. Anthony Fauci

CNBC Television

Gilead reports 'positive data' on Remdesivir coronavirus drug trial

CNBC Television

Gilead announces positive news for coronavirus patients in remdesivir trial

Remdesivir drug proved effective against virus in US study, maker says

6abc Philadelphia

Remdesivir potential treatment for COVID-19; White House, Wall Street seem optimistic | EWTN News Ni

EWTN

Gilead Covid-19 Drug Remdesivir Fails in Chinese Trial

Bloomberg Television

Gilead Drug Remdesivir Is a Rare Example of Foresight in the Coronavirus Pandemic

Bloomberg Quicktake

What Is Remdesivir, and How Does it Help Coronavirus Patients? | NBC New York

Fauci: Remdesivir Trial Is 'Opening The Door' To Possible Coronavirus Treatments | MSNBC

Gilead terminates study after coronavirus drug Remdesivir fails to improve recovery for COVID-19

BIG STORY | Why Remdesivir trial is significant in fight against COVID-19?

Gilead Sciences Confirms Breakthrough In Anti-COVID Drug Remdesivir

NDTV

Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'